Product details
              WHO Product ID
              WHOAPI-071
          Status
              Prequalified
          Date of prequalification
              Basis of listing
              Prequalification - Standard
          Therapeutic area
          HIV/AIDS
              Type
              None
          Grade
              Standard
          INN
              Efavirenz
          Confirmation of WHO API prequalification document (version date) 
              Applicant organization
              Matrix Pharmacorp Private Limited
    
            Plot No. 14, 99 and 100, IDA Pashamylaram Phase-II
      
              
        
        Patancheru, Sangareddy District,
        Telangana
      
            502307
      
            India
      
      APIMF Version Number
              MLL/EFD/AP/004/05, August 2021
MLL/EFD/RP/004/04, August 2021
MLL/EFD/AP/004/05, August 2021/Amend 01-Apr 2022
MLL/EFD/RP/004/04, August 2021/Amend 01-Apr 2022
MLL/EFD/AP/004/05, August 2021/Amend 02-Jun 2022
MLL/EFD/RP/004/04, August 2021/Amend 02-Jun 2022
MLL/EFD/AP/004/05, August 2021/Amend 03-December 2023
MLL/EFD/RP/004/04, August 2021/Amend 03-December 2023
MLL/EFD/RP/004/04, August 2021/Amend 04-March 2024
MLL/EFD/RP/004/04, August 2021/Amend 05-June 2024
MLL/EFD/AP/004/04, August 2021/Amend 04-June 2024
MLL/EFD/RP/004/04, August 2021/Amend 06-Sept 2025
MLL/EFD/AP/004/05, Aug 2021/Amend 05-Sept 2025
      
      MLL/EFD/RP/004/04, August 2021
MLL/EFD/AP/004/05, August 2021/Amend 01-Apr 2022
MLL/EFD/RP/004/04, August 2021/Amend 01-Apr 2022
MLL/EFD/AP/004/05, August 2021/Amend 02-Jun 2022
MLL/EFD/RP/004/04, August 2021/Amend 02-Jun 2022
MLL/EFD/AP/004/05, August 2021/Amend 03-December 2023
MLL/EFD/RP/004/04, August 2021/Amend 03-December 2023
MLL/EFD/RP/004/04, August 2021/Amend 04-March 2024
MLL/EFD/RP/004/04, August 2021/Amend 05-June 2024
MLL/EFD/AP/004/04, August 2021/Amend 04-June 2024
MLL/EFD/RP/004/04, August 2021/Amend 06-Sept 2025
MLL/EFD/AP/004/05, Aug 2021/Amend 05-Sept 2025
Product Grades
              API specification number
              CQA/STP/API/029/07
          Storage condition
              Do not store above 30°C, protect from light
          Storage period (months)
              60
          Duration type
              Retest period
          Packaging
              Efavirenz is first packed in white low-density polyethylene (LDPE) bag, twist-tied, which is placed in a black polyethylene bag, twist-tied and put into HDPE drum, closed and sealed.
          API Manufacturing Site(s)
  Matrix Pharmacorp Private Limited
      
            Unit 8, Gaitula Chodavaram, Poosapatirega Mandal, Vizianagaram
      
            Andhra Pradesh
      
            535 204
      
            India
      
      Matrix Pharmacorp Private Limited
      
            Unit 10, Plot No. 86, SEZ, Jawaharlal Nehru Pharma City, Parawada Mandal, Anakapalli District
      
              
        
        Visakhapatnam,
        Andhra Pradesh
      
            531019
      
            India